Resuscitation of a dead cardiomyocyte

Heart Failure Reviews

Volumn 20, Issue 6, 2015, Pages 709-719

  Kunkel, George H ^a   Chaturvedi, Pankaj ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Calpains; Cardiomyocytes; Homocysteine; Proteases; Resuscitation; Ubiquitin

Indexed keywords

CALMODULIN; CALPAIN; CALPAIN 1; CALPAIN 2; CASPASE 3; CASPASE 8; CASPASE 9; CELL PROTEIN; CHAPERONIN 60; CONNECTIN; GELATINASE A; GELATINASE B; HOMOCYSTEINE; MATRIX METALLOPROTEINASE; MICRORNA 29A; PURKINJE CELL PROTEIN 4; SMALL INTERFERING RNA; SOMATOMEDIN C; STROMELYSIN; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME 9; UNCLASSIFIED DRUG; PROTEASOME;

ARTICLE; CELL DEATH; CYTOSKELETON; EPIGENETICS; EXOSOME; GENE SILENCING; HEART FAILURE; HEART MUSCLE CELL; HUMAN; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RESUSCITATION; SARCOMERE; UBIQUITINATION; APOPTOSIS; CARDIAC MUSCLE CELL; CYTOLOGY; METABOLISM;

APOPTOSIS; HOMOCYSTEINE; HUMANS; MYOCYTES, CARDIAC; PROTEASOME ENDOPEPTIDASE COMPLEX; RESUSCITATION; UBIQUITIN;

EID: 84945492377     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-015-9501-z     Document Type: Article

References (64)

1. Muller AL, Freed D, Hryshko L, Dhalla NS (2012) Implications of protease activation in cardiac dysfunction and development of genetic cardiomyopathy in hamsters. Can J Physiol Pharmacol 90(8):995–1004. doi:10.1139/y2012-034
2. Letavernier E, Zafrani L, Perez J, Letavernier B, Haymann JP, Baud L (2012) The role of calpains in myocardial remodelling and heart failure. Cardiovasc Res 96(1):38–45. doi:10.1093/cvr/cvs099
3. Charton K, Sarparanta J, Vihola A, Milic A, Jonson PH, Suel L, Luque H, Boumela I, Richard I, Udd B (2015) CAPN3-mediated processing of C-terminal titin replaced by pathological cleavage in titinopathy. Hum Mol Genet. doi:10.1093/hmg/ddv116
4. Lindsey ML, Escobar GP, Mukherjee R, Goshorn DK, Sheats NJ, Bruce JA, Mains IM, Hendrick JK, Hewett KW, Gourdie RG, Matrisian LM, Spinale FG (2006) Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation 113(25):2919–2928. doi:10.1161/CIRCULATIONAHA.106.612960
5. Givvimani S, Kundu S, Narayanan N, Armaghan F, Qipshidze N, Pushpakumar S, Vacek TP, Tyagi SC (2013) TIMP-2 mutant decreases MMP-2 activity and augments pressure overload induced LV dysfunction and heart failure. Arch Physiol Biochem 119(2):65–74. doi:10.3109/13813455.2012.755548
6. Moshal KS, Camel CK, Kartha GK, Steed MM, Tyagi N, Sen U, Kang YJ, Lominadze D, Maldonado C, Tyagi SC (2007) Cardiac dys-synchronization and arrhythmia in hyperhomocysteinemia. Curr Neurovascular Res 4(4):289–294
7. Chaturvedi P, Kalani A, Givvimani S, Kamat PK, Familtseva A, Tyagi SC (2014) Differential regulation of DNA methylation versus histone acetylation in cardiomyocytes during HHcy in vitro and in vivo: an epigenetic mechanism. Physiol Genom 46(7):245–255. doi:10.1152/physiolgenomics.00168.2013
8. Chaturvedi P, Kalani A, Familtseva A, Kamat PK, Metreveli N, Tyagi SC (2015) Cardiac tissue inhibitor of matrix metalloprotease 4 dictates cardiomyocyte contractility and differentiation of embryonic stem cells into cardiomyocytes: road to therapy. Int J Cardiol 184C:350–363. doi:10.1016/j.ijcard.2015.01.091
9. Chaturvedi P, Kalani A, Medina I, Familtseva A, Tyagi SC (2015) Cardiosome mediated regulation of MMP9 in diabetic heart: role of mir29b and mir455 in exercise. J Cell Mol Med. doi:10.1111/jcmm.12589
10. Suzuki K, Hata S, Kawabata Y, Sorimachi H (2004) Structure, activation, and biology of calpain. Diabetes 53(suppl 1):S12–S18. doi:10.2337/diabetes.53.2007.S12
11. Suzuki K, Hata S, Kawabata Y, Sorimachi H (2004) Structure, activation, and biology of calpain. Diabetes 53(Suppl 1):S12–S18
12. Yang D, Ma S, Tan Y, Li D, Tang B, Zhang X, Sun M, Yang Y (2010) Increased expression of calpain and elevated activity of calcineurin in the myocardium of patients with congestive heart failure. Int J Mol Med 26(1):159–164
13. Parameswaran S, Sharma RK (2012) High molecular weight calmodulin-binding protein: 20 years onwards-a potential therapeutic calpain inhibitor. Cardiovasc Drugs Ther 26(4):321–330. doi:10.1007/s10557-012-6399-8
14. Campos C, Sundaram AYM, Valente LMP, Conceição LEC, Engrola S, Fernandes JMO (2014) Thermal plasticity of the miRNA transcriptome during senegalese sole development. BMC Genom 15(1):525. doi:10.1186/1471-2164-15-525
15. Kudo-Sakamoto Y, Akazawa H, Ito K, Takano J, Yano M, Yabumoto C, Naito AT, Oka T, Lee JK, Sakata Y, Suzuki J, Saido TC, Komuro I (2014) Calpain-dependent cleavage of N-cadherin is involved in the progression of post-myocardial infarction remodeling. J Biol Chem 289(28):19408–19419. doi:10.1074/jbc.M114.567206
16. Undrovinas A, Maltsev VA, Sabbah HN (2013) Calpain inhibition reduces amplitude and accelerates decay of the late sodium current in ventricular myocytes from dogs with chronic heart failure. PLoS ONE 8(4):e54436. doi:10.1371/journal.pone.0054436
17. Hogan PG, Chen L, Nardone J, Rao A (2003) Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17(18):2205–2232. doi:10.1101/gad.1102703
18. Wang JC, Zhao Y, Li XD, Zhou NN, Sun H, Sun YY (2012) Proteolysis by endogenous calpain I leads to the activation of calcineurin in human heart. Clin Lab 58(11–12):1145–1152
19. 2+/calmodulin-dependent protein kinase II delta mediates myocardial ischemia/reperfusion injury through nuclear factor-kappaB. Circ Res 112(6):935–944. doi:10.1161/circresaha.112.276915
20. Letavernier E, Zafrani L, Perez J, Letavernier B, Haymann J-P, Baud L (2012) The role of calpains in myocardial remodelling and heart failure. Cardiovasc Res. doi:10.1093/cvr/cvs099
21. Taneike M, Mizote I, Morita T, Watanabe T, Hikoso S, Yamaguchi O, Takeda T, Oka T, Tamai T, Oyabu J, Murakawa T, Nakayama H, Nishida K, Takeda J, Mochizuki N, Komuro I, Otsu K (2011) Calpain protects the heart from hemodynamic stress. J Biol Chem 286(37):32170–32177. doi:10.1074/jbc.M111.248088
22. Perrin C, Vergely C, Rochette L (2004) Calpains and cardiac diseases. Ann Cardiol Angeiol (Paris) 53(5):259–266
23. Müller A, Dhalla N (2012) Role of various proteases in cardiac remodeling and progression of heart failure. Heart Fail Rev 17(3):395–409. doi:10.1007/s10741-011-9269-8
24. Linke WA (2008) Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. Cardiovasc Res 77(4):637–648. doi:10.1016/j.cardiores.2007.03.029
25. Yamasaki R, Wu Y, McNabb M, Greaser M, Labeit S, Granzier H (2002) Protein kinase A phosphorylates titin’s cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes. Circ Res 90(11):1181–1188
26. Grutzner A, Garcia-Manyes S, Kotter S, Badilla CL, Fernandez JM, Linke WA (2009) Modulation of titin-based stiffness by disulfide bonding in the cardiac titin N2-B unique sequence. Biophys J 97(3):825–834. doi:10.1016/j.bpj.2009.05.037
27. Beckendorf L, Linke WA (2014) Emerging importance of oxidative stress in regulating striated muscle elasticity. J Muscle Res Cell Motil. doi:10.1007/s10974-014-9392-y
28. Lim CC, Sawyer DB (2005) Modulation of cardiac function: titin springs into action. J Gen Physiol 125(3):249–252. doi:10.1085/jgp.200509268
29. Galvez AS, Diwan A, Odley AM, Hahn HS, Osinska H, Melendez JG, Robbins J, Lynch RA, Marreez Y, Dorn GW 2nd (2007) Cardiomyocyte degeneration with calpain deficiency reveals a critical role in protein homeostasis. Circ Res 100(7):1071–1078. doi:10.1161/01.res.0000261938.28365.11
30. Gupta MK, Gulick J, Liu R, Wang X, Molkentin JD, Robbins J (2014) Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes. Circ Res 115(8):721–729. doi:10.1161/CIRCRESAHA.115.304760
31. Rajagopalan V, Zhao M, Reddy S, Fajardo G, Wang X, Dewey S, Gomes AV, Bernstein D (2013) Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure. Am J Physiol Heart Circ Physiol 305(4):H551–H562. doi:10.1152/ajpheart.00771.2012
32. Fessart D, Martin-Negrier ML, Claverol S, Thiolat ML, Crevel H, Toussaint C, Bonneu M, Muller B, Savineau JP, Delom F (2014) Proteomic remodeling of proteasome in right heart failure. J Mol Cell Cardiol 66:41–52. doi:10.1016/j.yjmcc.2013.10.015
33. Tang M, Li J, Huang W, Su H, Liang Q, Tian Z, Horak KM, Molkentin JD, Wang X (2010) Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts. Cardiovasc Res 88(3):424–433. doi:10.1093/cvr/cvq217
34. Meiners S, Dreger H, Fechner M, Bieler S, Rother W, Gunther C, Baumann G, Stangl V, Stangl K (2008) Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system. Hypertension 51(2):302–308. doi:10.1161/HYPERTENSIONAHA.107.097816
35. Stansfield WE, Tang RH, Moss NC, Baldwin AS, Willis MS, Selzman CH (2008) Proteasome inhibition promotes regression of left ventricular hypertrophy. Am J Physiol Heart Circ Physiol 294(2):H645–H650. doi:10.1152/ajpheart.00196.2007
36. Hedhli N, Lizano P, Hong C, Fritzky LF, Dhar SK, Liu H, Tian Y, Gao S, Madura K, Vatner SF, Depre C (2008) Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload. Am J Physiol Heart Circ Physiol 295(4):H1385–H1393. doi:10.1152/ajpheart.00532.2008
37. Engel D, Peshock R, Armstong RC, Sivasubramanian N, Mann DL (2004) Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. Am J Physiol Heart Circ Physiol 287(3):H1303–H1311. doi:10.1152/ajpheart.00053.2004
38. Isserlin R, Merico D, Wang D, Vuckovic D, Bousette N, Gramolini AO, Bader GD, Emili A (2015) Systems analysis reveals downregulation of a network of pro-survival miRNAs drives the apoptotic response in dilated cardiomyopathy. Mol BioSyst 11(1):239–251. doi:10.1039/c4mb00265b
39. Bironaite D, Daunoravicius D, Bogomolovas J, Cibiras S, Vitkus D, Zurauskas E, Zasytyte I, Rucinskas K, Labeit S, Venalis A, Grabauskiene V (2015) Molecular mechanisms behind progressing chronic inflammatory dilated cardiomyopathy. BMC Cardiovasc Disord 15(1):26. doi:10.1186/s12872-015-0017-1
40. Mao J, Lv Z, Zhuang Y (2014) MicroRNA-23a is involved in tumor necrosis factor-alpha induced apoptosis in mesenchymal stem cells and myocardial infarction. Exp Mol Pathol 97(1):23–30. doi:10.1016/j.yexmp.2013.11.005
41. Wang K, Liu F, Zhou LY, Ding SL, Long B, Liu CY, Sun T, Fan YY, Sun L, Li PF (2013) miR-874 regulates myocardial necrosis by targeting caspase-8. Cell Death Dis 4:e709. doi:10.1038/cddis.2013.233
42. Ma S, Zhang H, Sun W, Gong H, Wang Y, Ma C, Wang J, Cao C, Yang X, Tian J, Jiang Y (2013) Hyperhomocysteinemia induces cardiac injury by upregulation of p53-dependent Noxa and Bax expression through the p53 DNA methylation in ApoE(-/-) mice. Acta Biochim Biophys Sin 45(5):391–400. doi:10.1093/abbs/gmt030
43. Yang B, Ye D, Wang Y (2013) Caspase-3 as a therapeutic target for heart failure. Expert opinion on therapeutic targets 17(3):255–263. doi:10.1517/14728222.2013.745513
44. Mittal B, Mishra A, Srivastava A, Kumar S, Garg N (2014) Matrix metalloproteinases in coronary artery disease. Adv Clin Chem 64:1–72
45. Frati A, Ricci B, Pierucci F, Nistri S, Bani D, Meacci E (2015) Role of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxin. Mol Endocrinol 29(1):53–67. doi:10.1210/me.2014-1201
46. Polyakova V, Loeffler I, Hein S, Miyagawa S, Piotrowska I, Dammer S, Risteli J, Schaper J, Kostin S (2011) Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles. Int J Cardiol 151(1):18–33. doi:10.1016/j.ijcard.2010.04.053
47. Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J (2004) Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol 44(8):1609–1618. doi:10.1016/j.jacc.2004.07.023
48. Ali MA, Stepanko A, Fan X, Holt A, Schulz R (2012) Calpain inhibitors exhibit matrix metalloproteinase-2 inhibitory activity. Biochem Biophys Res Commun 423(1):1–5. doi:10.1016/j.bbrc.2012.05.005
49. Givvimani S, Munjal C, Tyagi N, Sen U, Metreveli N, Tyagi SC (2012) Mitochondrial division/mitophagy inhibitor (Mdivi) ameliorates pressure overload induced heart failure. PLoS ONE 7(3):e32388. doi:10.1371/journal.pone.0032388
50. Boysen G, Brander T, Christensen H, Gideon R, Truelsen T (2003) Homocysteine and risk of recurrent stroke. Stroke 34(5):1258–1261. doi:10.1161/01.str.0000069017.78624.37
51. Li Y, Li Y, Feng Q, Arnold JMO, Peng T (2009) Calpain activation contributes to hyperglycemia-induced apoptosis in cardiomyocytes. Cardiovasc Res. doi:10.1093/cvr/cvp189
52. Cheng Z, Jiang X, Pansuria M, Fang P, Mai J, Mallilankaraman K, Gandhirajan RK, Eguchi S, Scalia R, Madesh M, Yang X, Wang H (2014) Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via mu-calpain activation. Diabetes. doi:10.2337/db14-0784
53. Givvimani S, Qipshidze N, Tyagi N, Mishra PK, Sen U, Tyagi SC (2011) Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease. Int J Physiol Pathophysiol Pharmacol 3(2):107–119
54. Naruszewicz M, Jankowska EA, Zymlinski R, Bukowska H, Millo B, Banasiak W, Ponikowski P (2007) Hyperhomocysteinemia in patients with symptomatic chronic heart failure: prevalence and prognostic importance—pilot study. Atherosclerosis 194(2):408–414. doi:10.1016/j.atherosclerosis.2006.08.014
55. Moshal KS, Metreveli N, Frank I, Tyagi SC (2008) Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia. Curr Vasc Pharmacol 6(2):84–92
56. Raman IM, Tong G, Jahr CE (1996) Beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase. Neuron 16(2):415–421
57. Moshal KS, Singh M, Sen U, Rosenberger DS, Henderson B, Tyagi N, Zhang H, Tyagi SC (2006) Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Am J Physiol Heart Circ Physiol 291(6):H2825–H2835. doi:10.1152/ajpheart.00377.2006
58. Tyagi N, Moshal KS, Ovechkin AV, Rodriguez W, Steed M, Henderson B, Roberts AM, Joshua IG, Tyagi SC (2005) Mitochondrial mechanism of oxidative stress and systemic hypertension in hyperhomocysteinemia. J Cell Biochem 96(4):665–671. doi:10.1002/jcb.20578
59. Kim EE, Shekhar A, Lu J, Lin X, Liu FY, Zhang J, Delmar M, Fishman GI (2014) PCP4 regulates Purkinje cell excitability and cardiac rhythmicity. J Clin Investig 124(11):5027–5036. doi:10.1172/jci77495
60. Curran J, Tang L, Roof SR, Velmurugan S, Millard A, Shonts S, Wang H, Santiago D, Ahmad U, Perryman M (2014) Nitric oxide-dependent activation of CaMKII increases diastolic sarcoplasmic reticulum calcium release in cardiac myocytes in response to adrenergic stimulation. PLoS ONE 9(2):e87495
61. Yamaguchi T, Izumi Y, Nakamura Y, Yamazaki T, Shiota M, Sano S, Tanaka M, Osada-Oka M, Shimada K, Miura K, Yoshiyama M, Iwao H (2014) Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction. Int J Cardiol 178c:239–246. doi:10.1016/j.ijcard.2014.10.144
62. Gupta S, Knowlton AA (2007) HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol 292(6):H3052–H3056. doi:10.1152/ajpheart.01355.2006
63. Li Q, Su D, O’Rourke B, Pogwizd SM, Zhou L (2014) Mitochondria-derived ROS bursts disturb calcium cycling and induce abnormal automaticity in Guinea pig cardiomyocyte: a theoretical study. Am J Physiol Heart Circ Physiol. doi:10.1152/ajpheart.00493.2014
64. Bang C, Batkai S, Dangwal S, Gupta SK, Foinquinos A, Holzmann A, Just A, Remke J, Zimmer K, Zeug A, Ponimaskin E, Schmiedl A, Yin X, Mayr M, Halder R, Fischer A, Engelhardt S, Wei Y, Schober A, Fiedler J, Thum T (2014) Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Investig 124(5):2136–2146. doi:10.1172/jci70577